21 träffar

DrugSGLT2 inhibitor
Empagliflozin

Jardiance Synjardy Glyxambi SGLT2 inhibitor A diabetes drug now used mostly for reasons other than glucose control. Empagliflozin reduced cardiovascular death in type 2 diabetes…

Drugα- and β-agonist
Adrenaline

Adrenalin Stragen EpiPen Jext α- and β-agonist The only drug that reverses all components of anaphylaxis, and the cornerstone of cardiac arrest treatment. The…

DrugLong-acting dihydropyridine calcium channel blocker
Amlodipine

Norvasc Amlodipin Sandoz Amlodipine Teva Long-acting dihydropyridine calcium channel blocker A cornerstone drug for hypertension and stable angina, and the easiest calcium channel blocker…

DrugSelective If-channel inhibitor in the sinus node
Ivabradine

Procoralan Ivabradine Accord Selective If-channel inhibitor in the sinus node The only drug that reduces heart rate without affecting contractility, blood pressure, or conduction…

DrugNon-selective α-adrenergic blocker
Phentolamine

…selective alpha-blocker with onset within minutes and duration under half an hour. A niche drug: catecholamine-induced hypertensive crisis — phaeochromocytoma, cocaine and amphetamine intoxication…

DrugXanthine oxidase inhibitor
Allopurinol

…months require flare prophylaxis because falling urate levels themselves trigger attacks. Two features make this drug dangerous: the hypersensitivity syndrome and the combination with azathioprine.

DrugMuscarinic receptor antagonist (vagolytic)
Atropine

…nothing happens, which is the entire explanation for why the drug is ineffective in infranodal block. The effect comes within one minute and fades over…

DrugDirect thrombin inhibitor (factor IIa)
Dabigatran

…in patients who may need emergency surgery. The price is that approximately 80 % of absorbed drug is eliminated renally, so renal function governs treatment entirely…

DrugClass IC antiarrhythmic
Flecainide

…in structurally normal hearts. The CAST trial showed increased mortality after myocardial infarction — that boundary remains the most important fact in the drug's history.

DrugHigh-potency first-generation antipsychotic (butyrophenone)
Haloperidol

…and minimal anticholinergic burden. The drug has two entirely different dosing worlds: a few milligrams in acute psychotic agitation in younger patients, and tenths of…

DrugDirect-acting arteriolar vasodilator
Hydralazine

…making the drug unsuitable as first-line treatment in hypertensive crisis — but useful in pre-eclampsia and as afterload relief in combination with a nitrate…

DrugNon-selective COX inhibitor, propionic acid derivative
Ibuprofen

…quickly, which is an advantage: the drug suits as-needed use and can be discontinued with rapid recovery of renal function and platelet function. The…

DrugNon-selective β₁- and β₂-agonist without alpha effect
Isoprenaline

…while systemic vascular resistance and diastolic blood pressure fall, so the drug raises rate but not pressure. Used where rate itself is the problem: bradycardia…

DrugTricyclic antidepressant
Amitriptyline

…sodium-channel-mediated modulation, not on antidepressant action. What limits treatment is anticholinergic side effects, and what makes the drug dangerous is cardiotoxicity in overdose.

DrugInhaled corticosteroid in fixed combination with long-acting β₂-agonist
Budesonide/formoterol

…maintenance-and-reliever therapy in the same inhaler. The two regimens must never be confused — this is the most common prescribing error with this drug.

DrugLow molecular weight heparin
Dalteparin

…heparin, dalteparin is eliminated renally, so at eGFR below 30 ml/min the effect accumulates and the dose must be adjusted or the drug changed.

DrugSGLT2 inhibitor
Dapagliflozin

…with albuminuria, with or without diabetes. The dose is the same — 10 mg once daily — for all indications, making this drug unusually straightforward to manage.

DrugSynthetic vasopressin analogue (V2 agonist)
Desmopressin

…V2 receptor means it lacks the vasoconstrictive effect of vasopressin. The danger is not the drug itself but the fluid the patient drinks with it.

DrugSelective cholesterol absorption inhibitor
Ezetimibe

…placebo. IMPROVE-IT showed that the additional LDL lowering also translates into fewer cardiovascular events, making ezetimibe the first non-statin drug with outcome data.

DrugPancreatic hormone, glycogenolytic agent and inotrope
Glucagon

GlucaGen HypoKit Glucagon Novo Nordisk Baqsimi Ogluo Pancreatic hormone, glycogenolytic agent and inotrope Two entirely different drugs in the same ampoule. In severe hypoglycaemia, 1…

DrugNMDA-receptor antagonist, dissociative anaesthetic
Ketamine

…never a guarantee. The key practical distinction is between the three dose levels: analgesia, procedural sedation, and induction are different drugs in the same ampoule.